Cargando…

SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway

BACKGROUND: Prostate cancer (PCa) is the second leading cause of cancer-related male deaths worldwide. The purpose of this study was to investigate the effects of homo sapiens solute carrier family 4 member 4 (SLC4A4), which encodes the electrogenic Na(+)/HCO(3)(−) cotransporter isoform 1 (NBCe1), i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zelin, Wang, Qinghua, Zhai, Guanzhong, Ke, Shuai, Yu, Xi, Guo, Jia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933877/ https://www.ncbi.nlm.nih.gov/pubmed/35305629 http://dx.doi.org/10.1186/s12935-022-02546-6

Ejemplares similares

FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway
por: Ke, Shuai, et al.
Publicado: (2022)

Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway
por: Wang, Qinghua, et al.
Publicado: (2022)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

Knockdown of MCM8 inhibits development and progression of bladder cancer in vitro and in vivo
por: Zhu, Wei, et al.
Publicado: (2021)

Knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo
por: Bi, Guoshu, et al.
Publicado: (2021)

SFRP1 increases TMPRSS2-ERG expression promoting neoplastic features in prostate cancer in vitro and in vivo
por: Cruz-Hernández, Carlos D., et al.
Publicado: (2020)

LncRNA HOXD-AS1 promotes the metastasis of human hepatocellular carcinoma via modulating miR-326/SLC27A4
por: Ji, Wenbin, et al.
Publicado: (2020)

CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
por: Jiang, You, et al.
Publicado: (2021)

Midkine promotes glioblastoma progression via PI3K-Akt signaling
por: Hu, Beiquan, et al.
Publicado: (2021)

YY1 activates EMI2 and promotes the progression of cholangiocarcinoma through the PI3K/Akt signaling axis
por: Zhou, Shuai, et al.
Publicado: (2021)

LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2021)

SALL4 promotes gastric cancer progression via hexokinase II mediated glycolysis
por: Shao, Meng, et al.
Publicado: (2020)

SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer
por: Yao, Xingxing, et al.
Publicado: (2020)

Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
por: Zhu, Jialin, et al.
Publicado: (2020)

Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients
por: Deng, Haifeng, et al.
Publicado: (2019)

NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling
por: Chen, Yongbing, et al.
Publicado: (2021)

Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p
por: Wu, Huijuan, et al.
Publicado: (2020)

SLC25A22 promotes proliferation and metastasis by activating MAPK/ERK pathway in gallbladder cancer
por: Du, Pengcheng, et al.
Publicado: (2019)

The RelB alternative NF-kappaB subunit promotes autophagy in 22Rv1 prostate cancer cells in vitro and affects mouse xenograft tumor growth in vivo
por: Labouba, Ingrid, et al.
Publicado: (2014)

Hypoxia-mediated YTHDF2 overexpression promotes lung squamous cell carcinoma progression by activation of the mTOR/AKT axis
por: Xu, Peng, et al.
Publicado: (2022)

In vivo UVA irradiation of mouse is more efficient in promoting pulmonary melanoma metastasis than in vitro
por: Pastila, Riikka, et al.
Publicado: (2011)

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
por: Yu, Yan, et al.
Publicado: (2020)

Circular RNA-DPP4 serves an oncogenic role in prostate cancer progression through regulating miR-195/cyclin D1 axis
por: Yang, Deping, et al.
Publicado: (2021)

LncRNA JPX promotes cervical cancer progression by modulating miR-25-3p/SOX4 axis
por: Chen, Xia, et al.
Publicado: (2020)

Circ_0015756 promotes the progression of ovarian cancer by regulating miR-942-5p/CUL4B pathway
por: Du, Zhenhua, et al.
Publicado: (2020)

Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis
por: Wu, Luyao, et al.
Publicado: (2021)

Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway
por: Li, Mei, et al.
Publicado: (2021)

MAP7 promotes migration and invasion and progression of human cervical cancer through modulating the autophagy
por: Zhang, Li, et al.
Publicado: (2020)

Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade
por: Wang, Yan, et al.
Publicado: (2020)

SOX4 promotes the growth and metastasis of breast cancer
por: Zhang, Jing, et al.
Publicado: (2020)

Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
por: Yu, Chia-Cheng, et al.
Publicado: (2019)

Identifying SLC27A5 as a potential prognostic marker of hepatocellular carcinoma by weighted gene co-expression network analysis and in vitro assays
por: Zhang, Fan, et al.
Publicado: (2021)

LINC00689 promotes prostate cancer progression via regulating miR-496/CTNNB1 to activate Wnt pathway
por: Meng, Liwei, et al.
Publicado: (2020)

SHC4 promotes tumor proliferation and metastasis by activating STAT3 signaling in hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2022)

METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m(6)A modification
por: Xu, Yiming, et al.
Publicado: (2022)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Hexokinases 2 promoted cell motility and distant metastasis by elevating fibronectin through Akt1/p-Akt1 in cervical cancer cells
por: Chen, Qian, et al.
Publicado: (2021)

Alpha-synuclein contributes to malignant progression of human meningioma via the Akt/mTOR pathway
por: Ge, Yiqin, et al.
Publicado: (2016)

Promotion of tumor development in prostate cancer by progerin
por: Tang, Yong, et al.
Publicado: (2010)

Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway
por: Xu, Chaojian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g1uf7ahp3gi9v36jqtj9i5e29i